In each of those components, readers will access tips and resources on living with AMD, and get to know other people who are experiencing the disease and their families, like 81-year-old Bill Wall. Gordon, "and that's why we developed this program."ĮyeConnect is made up of three material components: an easy-to-read AMD Support Guide, called "The Life You Want is Still in Sight" an in-depth website ( and a regular, AMD-themed e-newsletter. "We don't want any Canadian to feel like they're facing AMD without support," says Dr. At the time of diagnosis, people with AMD generally feel a lack of support to help them overcome the challenges of vision loss. The first-of-its-kind program is one of the most comprehensive resources ever developed for people with AMD - supporting not only patients, but family members, with timely referrals to CNIB's range of rehabilitation programs and AMD services, like training on how to live with reduced vision, and access to information and treatments for the disease.Ī recent Ipsos survey indicated that awareness of AMD in Canada is low. "From now on, Canadians dealing with AMD will know they're not alone, and that they have the practical and emotional support they need every step of the way." Keith Gordon, CNIB's Vice President Research and Service Quality. "EyeConnect is a sophisticated program that fills an incredible need in this country," says Dr. More Canadians have AMD than breast cancer, prostate cancer, Alzheimer's and Parkinson's combined. 23 /CNW/ - CNIB launches its new EyeConnect AMD Support program today, a comprehensive support system for Canada's leading cause of vision loss, age-related macular degeneration (AMD). This initiative is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.Comprehensive help now available for people living with AMD The partners of the EyeConnect education collaborative recognize the value and importance of collaborative education to incorporate a synergistic instructional design that combines clinical, communication, and educational skills to support the medical community and patients with DR," says Scott Scire, Vice President of Collaborative Partnerships at Paradigm Medical Communications, LLC. "Collaborative educational initiatives are critical to the development and implementation of educational activities that will help clinicians expand and enhance their understanding of the management of DR. This goal reflects a patient-centered, evidence-based shift from reactive (watch and wait) DR care to proactive DR care. Therefore, this initiative will address the unique educational needs of each key clinician audience (endocrinologists, family physicians, internists, nurse practitioners, ophthalmologists, optometrists, physician assistants, residents/fellows, and retina specialists), while also providing access to patient education resources, to catalyze earlier patient referral and intervention for DR, with the goal of initiating treatment before vision-threatening complications develop. Because the contributing factors are multidisciplinary, improving outcomes requires the concerted and proactive efforts of the wide range of clinicians who are essential to the ongoing, lifelong care of patients who either have or are at risk for DR, ranging from those who initially assess and diagnose DR, to those who treat DR. DR remains the leading cause of blindness in working-age US adults. 21, 2022 /PRNewswire/ - The educational collaborative of Paradigm Medical Communications, LLC, American Association of Nurse Practitioners ® (AANP), American Academy of Physician Associates (AAPA), California Academy of Family Physicians (CAFP), the Endocrine Society,, Global Education Group, Healio CME, Komodo Health, National Minority Quality Forum (NMQF) Center for Sustainable Health Care Quality and Equity (SHC), along with its community networks of Faith Health Alliance and HAIR Wellness Warriors, Pennsylvania College of Optometry at Salus University, and RealCME/Gather-ed, announce the launch of EyeConnect,, a multimethod continuing education initiative that will address gaps and needs of the patient journey in the management of diabetic retinopathy (DR).ĭespite the availability of effective treatments, preventable DR-related vision loss and blindness remain persistent problems, often due to delays in evaluation, diagnosis, and treatment, especially in underserved patient populations.
0 Comments
Leave a Reply. |